NexImmune, Inc.NexImmune, Inc.NexImmune, Inc.

NexImmune, Inc.

No trades
See on Supercharts
Market capitalization
‪4.27 M‬USD
−267.72USD
‪−62.51 M‬USD
‪788.80 K‬
Beta (1Y)
−0.24

About NexImmune, Inc.

CEO
Kristi Jones
Headquarters
Gaithersburg
Employees (FY)
50
Founded
2011
ISIN
US65344D2080
FIGI
BBG007SK6360
NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke on June 7, 2011 and is headquartered in Gaithersburg, MD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NEXI is 3.61 USD — it has decreased by 8.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NexImmune, Inc. stocks are traded under the ticker NEXI.
NexImmune, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for NexImmune, Inc. has a max estimate of 7.00 USD and a min estimate of 7.00 USD.
NEXI earnings for the last quarter are −9.25 USD whereas the estimation was −11.63 USD which accounts for 20.43% surprise. Estimated earnings for the next quarter are −7.25 USD. See more details about NexImmune, Inc. earnings.
Yes, you can track NexImmune, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, NEXI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NexImmune, Inc. stock right from TradingView charts — choose your broker and connect to your account.
NEXI reached its all-time high on Feb 12, 2021 with the price of 700.00 USD, and its all-time low was 1.25 USD and was reached on Nov 24, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 50.00 employees. See our rating of the largest employees — is NexImmune, Inc. on this list?